301 related articles for article (PubMed ID: 15045145)
21. Increased soluble fibrin in plasma of patients with disseminated intravascular coagulation.
Wada H; Sase T; Matsumoto T; Kushiya F; Sakakura M; Mori Y; Nishikawa M; Ohnishi K; Nakatani K; Gabazza EC; Shiku H; Nobori T
Clin Appl Thromb Hemost; 2003 Jul; 9(3):233-40. PubMed ID: 14507112
[TBL] [Abstract][Full Text] [Related]
22. Fibrin degradation products, fibrin monomer and soluble fibrin in disseminated intravascular coagulation.
Horan JT; Francis CW
Semin Thromb Hemost; 2001 Dec; 27(6):657-66. PubMed ID: 11740689
[TBL] [Abstract][Full Text] [Related]
23. Comparison of diagnostic criteria for disseminated intravascular coagulation (DIC): diagnostic criteria of the International Society of Thrombosis and Hemostasis and of the Japanese Ministry of Health and Welfare for overt DIC.
Wada H; Gabazza EC; Asakura H; Koike K; Okamoto K; Maruyama I; Shiku H; Nobori T
Am J Hematol; 2003 Sep; 74(1):17-22. PubMed ID: 12949885
[TBL] [Abstract][Full Text] [Related]
24. Utility of the fibrinogen/C-reactive protein ratio for the diagnosis of disseminated intravascular coagulation.
Kim HK; Lee DS; Kang SH; Kim JQ; Park S; Cho HI
Acta Haematol; 2007; 117(1):34-9. PubMed ID: 17095857
[TBL] [Abstract][Full Text] [Related]
25. Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation.
Kim JE; Lee N; Gu JY; Yoo HJ; Kim HK
Thromb Res; 2015 Jun; 135(6):1064-9. PubMed ID: 25843168
[TBL] [Abstract][Full Text] [Related]
26. Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
Seo JW; Kim HK; Kim JE; Park S; Cho HI
Thromb Res; 2009 Feb; 123(4):565-72. PubMed ID: 18479738
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of the innovance d-dimer assay for the diagnosis of disseminated intravascular coagulopathy in different clinical settings.
Khalafallah A; Jarvis C; Morse M; Albarzan AM; Stewart P; Bates G; Hayes R; Robertson I; Seaton D; Brain T
Clin Appl Thromb Hemost; 2014 Jan; 20(1):91-7. PubMed ID: 22859588
[TBL] [Abstract][Full Text] [Related]
28. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
Xu Y; Zhu R; Sun Y; Li X; Ma X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Disseminated Intravascular Coagulation in Critically Ill Pediatric Hemato-oncology Patients with Septic Shock.
Jhang WK; Park SJ
Thromb Haemost; 2020 Nov; 120(11):1505-1511. PubMed ID: 32772349
[TBL] [Abstract][Full Text] [Related]
30. Diagnosis of overt disseminated intravascular coagulation: a comparative study using criteria from the International Society versus the Korean Society on Thrombosis and Hemostasis.
Lee JH; Song JW; Song KS
Yonsei Med J; 2007 Aug; 48(4):595-600. PubMed ID: 17722230
[TBL] [Abstract][Full Text] [Related]
31. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
El-Nawawy A; Abbassy AA; El-Bordiny M; Essawi S
J Trop Pediatr; 2004 Dec; 50(6):339-47. PubMed ID: 15537719
[TBL] [Abstract][Full Text] [Related]
33. Clinical value of automated fibrin generation markers in patients with septic shock: a SepsiCoag ancillary study.
Gris JC; Cochery-Nouvellon E; Bouvier S; Jaber S; Albanese J; Constantin JM; Orban JC; Morel J; Leone M; Deras P; Elotmani L; Lavigne-Lissalde G; Lefrant JY
Br J Haematol; 2018 Nov; 183(4):636-647. PubMed ID: 30203833
[TBL] [Abstract][Full Text] [Related]
34. Increased plasma-soluble fibrin monomer levels in patients with disseminated intravascular coagulation.
Wada H; Wakita Y; Nakase T; Shimura M; Hiyoyama K; Nagaya S; Deguchi H; Mori Y; Kaneko T; Deguchi K; Fujii J; Shiku H
Am J Hematol; 1996 Apr; 51(4):255-60. PubMed ID: 8602623
[TBL] [Abstract][Full Text] [Related]
35. Prospective evaluation of three different diagnostic criteria for disseminated intravascular coagulation.
Takemitsu T; Wada H; Hatada T; Ohmori Y; Ishikura K; Takeda T; Sugiyama T; Yamada N; Maruyama K; Katayama N; Isaji S; Shimpo H; Kusunoki M; Nobori T
Thromb Haemost; 2011 Jan; 105(1):40-4. PubMed ID: 20941463
[TBL] [Abstract][Full Text] [Related]
36. A prospective comparative study of three sets of criteria for disseminated intravascular coagulation: ISTH criteria vs Japanese criteria.
Hayakawa M; Gando S; Hoshino H
Clin Appl Thromb Hemost; 2007 Jan; 13(1):65-72. PubMed ID: 17164497
[TBL] [Abstract][Full Text] [Related]
37. Analytic validation and clinical evaluation of the STA LIATEST immunoturbidimetric D-dimer assay for the diagnosis of disseminated intravascular coagulation.
Lehman CM; Wilson LW; Rodgers GM
Am J Clin Pathol; 2004 Aug; 122(2):178-84. PubMed ID: 15323133
[TBL] [Abstract][Full Text] [Related]
38. ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D-dimer assay.
Gris JC; Faillie JL; Cochery-Nouvellon E; Lissalde-Lavigne G; Lefrant JY
J Thromb Haemost; 2011 Jun; 9(6):1252-5. PubMed ID: 21645228
[No Abstract] [Full Text] [Related]
39. D-dimer test: diagnostic role in clinical and sub-clinical DIC.
Saxena R; Gupta PK; Ahmed R; Batra V; Kumar S
Indian J Pathol Microbiol; 2003 Jul; 46(3):425-6. PubMed ID: 15025290
[TBL] [Abstract][Full Text] [Related]
40. Tissue factor pathway inhibitor and P-selectin as markers of sepsis-induced non-overt disseminated intravascular coagulopathy.
Mosad E; Elsayh KI; Eltayeb AA
Clin Appl Thromb Hemost; 2011 Feb; 17(1):80-7. PubMed ID: 19689998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
